# Effects of Laurocerasus Officinalis Roem (Cherry Laurel) on Cognitive Function and Neurobiochemical Pathways in a Streptozotocin-Induced Nontransgenic Alzheimer’s Disease Model

**Authors:** Fulya Ozsoy, Karolin Yanar, Ugurcan Sayili, Pinar Atukeren, Hafize Uzun

PMC · DOI: 10.3390/nu18050867 · Nutrients · 2026-03-08

## TL;DR

This study shows that cherry laurel improves cognitive function and reduces Alzheimer's-related markers in a rat model, possibly through antioxidant and anti-amyloid effects.

## Contribution

The study is the first to demonstrate the cognitive and neurobiochemical benefits of Laurocerasus officinalis in a nontransgenic Alzheimer's model.

## Key findings

- Cherry laurel increased glutathione levels in both Alzheimer's and diabetes models.
- Cherry laurel reduced amyloid-beta and acetylcholinesterase levels in the Alzheimer's model.
- Cherry laurel improved spatial learning performance in the Alzheimer's model.

## Abstract

Background: This study investigated the effects of Laurocerasus officinalis Roem (cherry laurel; CL), a traditionally consumed fruit, on cognitive performance and selected neurobiochemical and metabolic pathways in a nontransgenic streptozotocin (STZ)-induced Alzheimer’s disease (i.c.v. STZ) model and an STZ-induced type 2 diabetes mellitus (T2DM; i.p. STZ) model. Method: Fifty-seven adult male Sprague–Dawley rats were allocated to control, T2DM, and Alzheimer (ALZ) model groups, with subgroup interventions including CL supplementation and, in the T2DM model, metformin as a comparator. Spatial learning and memory were assessed using the Morris Water Maze. Serum and brain tissue levels of GSK3-β, glutathione (GSH), interleukin-1 (IL-1), GLUT4, GLP-1, β-amyloid (Aβ), and acetylcholinesterase (AChE) were quantified. Results: Serum GSK3-β levels did not differ significantly between groups, whereas brain tissue GSK3-β showed significant between-group differences. CL increased GSH levels in both models, with significant elevations in serum and brain tissue GSH in the ALZ model following CL administration; in the T2DM model, GSH increased after both CL and metformin. In the ALZ model, CL was associated with decreased serum Aβ and AChE levels and improved Morris Water Maze performance, reflected by reduced escape latencies. Conclusions: CL supplementation was associated with antioxidant enhancement and modulation of amyloid- and cholinergic-related measures, alongside improved spatial learning performance in the STZ-induced nontransgenic ALZ model. In addition, CL reduced blood glucose in the T2DM model. Given the likely contribution of fruit phytochemicals (including total phenolics), further studies are warranted to better define the bioactive composition and mechanisms underlying these effects.

## Linked entities

- **Proteins:** GSK3B (glycogen synthase kinase 3 beta), SLC2A4 (solute carrier family 2 member 4), GCG (glucagon)
- **Chemicals:** glutathione (PubChem CID 124886)
- **Diseases:** Alzheimer’s disease (MONDO:0004975), type 2 diabetes mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** App (amyloid beta precursor protein) [NCBI Gene 54226] {aka Abeta}, Ache (acetylcholinesterase) [NCBI Gene 83817], Gcg (glucagon) [NCBI Gene 24952] {aka GLP-1, Glp1, Glp2}, Slc2a4 (solute carrier family 2 member 4) [NCBI Gene 25139] {aka Glut4}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 84027]
- **Diseases:** T2DM (MESH:D003924), ALZ (MESH:D000544)
- **Chemicals:** STZ (MESH:D013311), Cherry Laurel (-), glutathione (MESH:D005978), CL (MESH:D002713), metformin (MESH:D008687), glucose (MESH:D005947)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12986940/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12986940/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12986940/full.md

---
Source: https://tomesphere.com/paper/PMC12986940